Linee Guida - Iperlipidemie e sindrome metabolica

Arnold MA, et al.
A synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline for lipid management for cardiovascular disease risk reduction.
Ann Intern Med 2026, 179: 1460-72 (free full text).


Patel SB, et al.
American Association of Clinical Endocrinology clinical practice guideline on pharmacologic management of adults with dyslipidemia.
Endocr Pract 2025, 31: 236-62 (free full text).


Newman CB, et al.
Lipid management in patients with endocrine disorders: an Endocrine Society clinical practice guideline
J Clin Endocrinol Metab 2020, 105: dgaa674 (free full text).


Rosenzweig JL, et al.
Primary prevention of ASCVD and T2DM in patients at metabolic risk: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab 2019, 104: 3939–85 (free full text).


Arnett DK, et al.
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease.
J Am Coll Cardiol 2019, DOI: 10.1016/j.jacc.2019.03.010.